Arvinas, Inc. (ARVN)
8.45
-0.26
(-2.99%)
USD |
NASDAQ |
Sep 11, 16:00
8.35
-0.10
(-1.18%)
After-Hours: 20:00
Arvinas Price : 8.45 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 8.82 | 8.915 | 8.365 | 8.45 | 908559.0 |
| Sep 10, 2026 | 8.67 | 8.775 | 8.47 | 8.71 | 776727.0 |
| Sep 09, 2026 | 9.085 | 9.10 | 8.75 | 8.76 | 738471.0 |
| Sep 08, 2026 | 9.23 | 9.34 | 8.97 | 9.08 | 570720.0 |
| Sep 04, 2026 | 9.31 | 9.455 | 9.22 | 9.39 | 449299.0 |
| Sep 03, 2026 | 9.68 | 9.691 | 9.21 | 9.31 | 501476.0 |
| Sep 02, 2026 | 9.28 | 9.64 | 9.27 | 9.59 | 548800.0 |
| Sep 01, 2026 | 9.14 | 9.30 | 9.060 | 9.28 | 491141.0 |
| Aug 31, 2026 | 9.12 | 9.27 | 8.960 | 9.20 | 659720.0 |
| Aug 28, 2026 | 9.17 | 9.235 | 9.03 | 9.18 | 600338.0 |
| Aug 27, 2026 | 9.27 | 9.43 | 9.15 | 9.24 | 527006.0 |
| Aug 26, 2026 | 9.53 | 9.545 | 9.28 | 9.32 | 532587.0 |
| Aug 25, 2026 | 9.39 | 9.74 | 9.39 | 9.60 | 530606.0 |
| Aug 24, 2026 | 9.28 | 9.39 | 9.06 | 9.34 | 500358.0 |
| Aug 21, 2026 | 9.02 | 9.39 | 9.00 | 9.365 | 951752.0 |
| Aug 20, 2026 | 9.55 | 9.63 | 8.97 | 9.025 | 601732.0 |
| Aug 19, 2026 | 9.44 | 9.69 | 9.44 | 9.68 | 494207.0 |
| Aug 18, 2026 | 9.19 | 9.332 | 9.10 | 9.26 | 554727.0 |
| Aug 17, 2026 | 8.91 | 9.26 | 8.894 | 9.20 | 584029.0 |
| Aug 14, 2026 | 8.91 | 8.975 | 8.72 | 8.97 | 461290.0 |
| Aug 13, 2026 | 8.91 | 9.09 | 8.855 | 9.01 | 939144.0 |
| Aug 12, 2026 | 8.99 | 8.99 | 8.71 | 8.87 | 524458.0 |
| Aug 11, 2026 | 8.99 | 9.115 | 8.86 | 8.99 | 572103.0 |
| Aug 10, 2026 | 8.70 | 9.02 | 8.590 | 8.99 | 671770.0 |
| Aug 07, 2026 | 8.81 | 8.98 | 8.64 | 8.75 | 1.218M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cocrystal Pharma, Inc. | 1.24 |
| CNBX Pharmaceuticals, Inc. | 0.0001 |
| GB Sciences, Inc. | 0.0002 |
| Fulcrum Therapeutics, Inc. | 3.80 |
| Definium Therapeutics, Inc. | 38.89 |
Price Related Metrics
| PE Ratio | 52.68 |
| PS Ratio | 1.786 |
| Price to Book Value | 0.9815 |
| Earnings Yield | 1.90% |
| Market Cap | 551.78M |
| Normalized PE Ratio | 38.62 |